China Sky One Predicts Improved 2010; Changes Focus

China Sky One Medical (中国天字一号医药公司) expects 2010 revenues to grow by 20% to $156 million. Net income, however, will increase by a more modest 13% to $39 million, as the company ups its R&D to 15% of revenue. At the same time, the company said it will shift its corporate focus to cardiovascular medicine and antibiotic drugs. More details... Stock Symbol: (NSDQ: CSKI)